Explore 3 Stock Ideas & Industry Insights Download Free Report

Company price
0.005 CAD 0.00(0%)
Last update at 2026-11-03T14:30:00Z
Market Cap
0.57M

Momentum Score

…

NAVCO Pharmaceuticals Inc. develops and commercializes supplemental and therapeutic consumer health and wellness products in the areas of antibacterial and immunity support and infectious disease prevention in Canada. The company offers aerosol sprays, hand cleansers, hand creams, and nano bioguard; and disinfectant spray products. It also provides diagnostic testing, textile, PPE, and food solutions. Its products are used in medicine, textiles, chemicals, and additives industries to combat microorganisms. NAVCO Pharmaceuticals Inc. is headquartered in Vancouver, Canada.

Source: TradingView
The charts and visual representations are sourced from TradingView through embedded widgets. For any issues with chart display, please visit the TradingView website

Day Price Range
0.01
Low
0.01
High
52 Week Price Range
0.01
Low
0.01
High

Momentum Score

…
Loading momentum score…

A unique technical analysis driven score developed by Kalkine showing momentum in stock prices based on select technical indicators identified.

Score - Rating
>= 1 - Low / > 1 but < 2 - Below Average / > 2 but < 3 - Average / > 3 but < 4 - Above Average / > 4 - High
AI Summary

Public information on Navasota Resources Inc. (NAV.V) is limited, so the company's core activities, assets and major long-term growth drivers are not clearly disclosed in widely available filings. Investors may find the stock of interest only if prepared to perform direct due diligence and accept potential upside and information risk associated with small, early-stage resource issuers.

Risk Score
High

Note: The summary and risk score provided above is created by AI and should not be construed as a recommendation of Kalkine.

Key Metrics*

Previous Close
0.01
Dividend Yield
-
Revenue TTM
0.01M
Revenue Per Share
-
Gross Profit TTM
0.06M
Debt / Equity
-
ROE
-
Net Debt
-
ROCE
-2882.83%
Diluted EPS TTM
-0.06

Key Financials*

Income Statement

Balance Sheet

Change in Cash

Total Operating Cash

Dividends Paid

Breakdown 2022-09-30 2021-09-30
Type yearly yearly
Date 2022-09-30 2021-09-30
Income before tax -0.09M -0.07M
Net income -0.09M -0.07M
Selling general administrative 0.07M 0.06M
Operating income -0.10M -0.08M
Interest income 0.01M 0.01M
Net interest income 0.01M 0.01M
Total revenue 0.00M 0.00M
Total operating expenses 0.10M 0.08M
Net income from continuing ops -0.09M -0.07M
Breakdown 2022-09-30 2021-09-30
Type yearly yearly
Date 2022-09-30 2021-09-30
Total assets 0.11M 0.12M
Total liab 0.11M 0.02M
Total stockholder equity 0.00M 0.10M
Capital stock 0.32M 0.32M
Retained earnings -0.40M -0.31M
Cash 0.00M 0.01M
Total current liabilities 0.11M 0.02M
Total current assets 0.11M 0.12M
Accounts payable 0.06M 0.01M
Non current assets total 0.00M 0.00M
Breakdown 2022-09-30 2021-09-30
Type yearly yearly
Date 2022-09-30 2021-09-30
Total cash from financing activities 0.00M -0.09M
Net income -0.09M -0.07M
Change in cash -0.01M -0.17M
Begin period cash flow 0.01M 0.18M
End period cash flow 0.00M 0.01M
Total cash from operating activities -0.01M -0.08M
Capital expenditures 0.00M 0.00M
Change in working capital 0.09M -0.00M
Other non cash items -0.01M -0.01M
Free cash flow -0.01M -0.08M

Peer Comparison*

Sector: Healthcare Industry: Drug Manufacturers - Specialty & Generic

Stock Name
Change
(CAD)
Price
(CAD)
Trailing
PE (x)
Forward
PE (x)
Price Sales
TTM (x)
Price to Book Value (x)
Enterprise Value
to Revenue (x)
NAV
Navasota Resources Inc.
-
-%
0.01 - - 2.47 - 14.28
RX
Biosyent Inc.
0.30
1.78%
17.15 19.10 15.85 3.96 4.11 3.31
DB
Decibel Cannabis Company Inc
0.21
11.67%
2.01 - 8.67 0.67 1.20 0.99
ZYUS
ZYUS Life Sciences Corporation
0.03
9.38%
0.35 - - 108.48 4.41 140.29
LSL
LSL Pharma Group Inc.
0.01
1.64%
0.31 20.75 - 1.88 1.89 2.85

Profile*

Navasota Resources Inc.

NAVCO Pharmaceuticals Inc. develops and commercializes supplemental and therapeutic consumer health and wellness products in the areas of antibacterial and immunity support and infectious disease prevention in Canada. The company offers aerosol sprays, hand cleansers, hand creams, and nano bioguard; and disinfectant spray products. It also provides diagnostic testing, textile, PPE, and food solutions. Its products are used in medicine, textiles, chemicals, and additives industries to combat microorganisms. NAVCO Pharmaceuticals Inc. is headquartered in Vancouver, Canada.

1170 ? 1040 West Georgia Street, Vancouver, BC, Canada, V6E 4H1

Name Title Year Born
Mr. Geoffrey Lee Chief Executive Officer NA
Mr. Christopher R. Cooper Chief Financial Officer 1971
Mr. Marek Jasinski COO & Director 1977
Mr. Thomas Jusdanis Corporate Secretary & Independent Director 1958

Disclaimer - (*)This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on an ‘as is’ basis, using their API. We cannot guarantee the completeness or validity of the information and data provided on this page, as well as via the API. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general information purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine is not liable for any errors or omissions in the information provided or for any actions taken in reliance on it. You should seek advice from a financial adviser, stockbroker or other professional adviser (including taxation and legal advice) as necessary before acting on this information.

Support

Hi! How can we help you today?

Loading…